Consumption of monosodium glutamate in relation to incidence of overweight in Chinese adults: China Health and Nutrition Survey (CHNS)

American Journal of Clinical Nutrition

Volumn 93, Issue 6, 2011, Pages 1328-1336

  He, Ka ^a,b   Du, Shufa ^a   Xun, Pengcheng ^a,b   Sharma, Sangita ^a,c,d   Wang, Huijun ^e   Zhai, Fengying ^e   Popkin, Barry ^a  

^a University of North Carolina   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE SODIUM;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; DIETARY INTAKE; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OBESITY;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHINA; DIET; DIET RECORDS; DIET SURVEYS; FEMALE; FLAVORING AGENTS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NUTRITION SURVEYS; OVERWEIGHT; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; SODIUM GLUTAMATE; YOUNG ADULT;

EID: 79956317661     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.008870     Document Type: Article

References (67)

1. Ito M. Domestic and overseas food products business FY 2008-2010 medium term plan. Available from: http://www.ajinomoto.com/ir/pdf/08July02-food-E.pdf (cited 12 September 2009).
2. Erb JE, Erb TM. The slow poisoning of America. Virginia Beach:, VA Paladins Press, 2003.
3. GRAS Committee on GRAS List Survey. Estimating distributions of daily intake of monosodium glutamate (MSG). Washington, DC: Food and Nutrition Board, Division of Biological Sciences, Assembly of Life Sciences, 1979.
4. Rhodes J, Titherley AC, Norman JA, Wood R, Lord DW. A survey of the monosodium glutamate content of foods and an estimation of the dietary intake of monosodium glutamate. Food Addit Contam 1991;8:663-72.
5. Beyreuther K, Biesalski HK, Fernstrom JD, et al. Consensus meeting: monosodium glutamate - an update. Eur J Clin Nutr 2007;61:304-13. (Pubitemid 46358769)
6. Collison KS, Maqbool Z, Saleh SM, et al. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease. J Lipid Res 2009;50:1521-37.
7. Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 1969;164:719-21.
8. Dawson R, Pelleymounter MA, Millard WJ, Liu S, Eppler B. Attenuation of leptin-mediated effects by monosodium glutamate-induced arcuate nucleus damage. Am J Physiol 1997;273:E202-6.
9. Tang-Christensen M, Holst JJ, Hartmann B, Vrang N. The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin. Neuroreport 1999;10:1183-7. (Pubitemid 29403691)
10. Bergen HT, Mizuno TM, Taylor J, Mobbs CV. Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin. Endocrinology 1998;139:4483-8. (Pubitemid 28487763)
11. He K, Zhao L, Daviglus ML, et al. Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study. Obesity (Silver Spring) 2008;16:1875-80.
12. Yeomans MR, Gould NJ, Mobini S, Prescott J. Acquired flavor acceptance and intake facilitated by monosodium glutamate in humans. Physiol Behav 2008;93:958-66.
13. Bellisle F, Monneuse MO, Chabert M, Larue-Achagiotis C, Lanteaume MT, Louis-Sylvestre J. Monosodium glutamate as a palatability enhancer in the European diet. Physiol Behav 1991;49:869-73.
14. Hermanussen M, Garcia AP, Sunder M, Voigt M, Salazar V, Tresguerres JA. Obesity, voracity, and short stature: the impact of glutamate on the regulation of appetite. Eur J Clin Nutr 2006;60:25-31. (Pubitemid 43731071)
15. Hermanussen M, Tresguerres JA. Does high glutamate intake cause obesity? J Pediatr Endocrinol Metab 2003;16:965-8.
16. Hermanussen M, Tresguerres JA. Does the thrifty phenotype result from chronic glutamate intoxication? A hypothesis. J Perinat Med 2003;31:489-95. (Pubitemid 38057005)
17. Popkin BM, Du S, Zhai F, Zhang B. The China Health and Nutrition Survey: monitoring and understanding socioeconomic and health change in China 1989-2011. Int J Epidemiol 2010;39:1435-40.
18. Zhai F, Guo X, Popkin BM, et al. Evaluation of the 24-hour individual recall method in China. Tokyo, Japan: United Nations University; 1996.
19. Popkin BM, Lu B, Zhai F. Understanding the nutrition transition: measuring rapid dietary changes in transitional countries. Public Health Nutr 2002;5(6A):947-53.
20. Switzer BR, Stark AH, Atwood JR, Ritenbaugh C, Travis RG, Wu HM. Development of a urinary riboflavin adherence marker for a wheat bran fiber community intervention trial. Cancer Epidemiol Biomarkers Prev 1997;6:439-42. (Pubitemid 27270549)
21. Yao M, McCrory MA, Ma G, et al. Relative influence of diet and physical activity on body composition in urban Chinese adults. Am J Clin Nutr 2003;77:1409-16. (Pubitemid 39655273)
22. Monda KL, Adair LS, Zhai F, Popkin BM. Longitudinal relationships between occupational and domestic physical activity patterns and body weight in China. Eur J Clin Nutr 2008;62:1318-25.
23. Bell AC, Ge K, Popkin BM. Weight gain and its predictors in Chinese adults. Int J Obes Relat Metab Disord 2001;25:1079-86. (Pubitemid 32566066)
24. Bell AC, Ge K, Popkin BM. The road to obesity or the path to prevention: motorized transportation and obesity in China. Obes Res 2002;10:277-83. (Pubitemid 135688236)
25. Paeratakul S, Popkin BM, Keyou G, Adair LS, Stevens J. Changes in diet and physical activity affect the body mass index of Chinese adults. Int J Obes Relat Metab Disord 1998;22:424-31. (Pubitemid 28211970)
26. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000;32(suppl):S498-504.
27. Monda KL, Gordon-Larsen P, Stevens J, Popkin BM. China's transition: the effect of rapid urbanization on adult occupational physical activity. Soc Sci Med 2007;64:858-70. (Pubitemid 46084976)
28. Ng SW, Norton EC, Popkin BM. Why have physical activity levels declined among Chinese adults? Findings from the 1991-2006 China Health and Nutrition Surveys. Soc Sci Med 2009;68:1305-14.
29. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-63.
30. International Obesity Task Force (on behalf of the Steering Committee). The Asia-Pacific perspective: redefining obesity and its treatment. Western Pacific Region. Sydney, Australia: Health Communications Australia Pty Ltd, 2002.
31. Von Korff M, Koepsell T, Curry S, Diehr P. Multi-level analysis in epidemiologic research on health behaviors and outcomes. Am J Epidemiol 1992;135:1077-82.
32. Greenland S. Randomization, statistics, and causal inference. Epidemiology 1990;1:421-9.
33. Shi Z, Luscombe-Marsh ND, Wittert GA, et al. Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: findings from the Jiangsu Nutrition Study of Chinese adults. Br J Nutr 2010;104:457-63.
34. Samuels A. Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: findings from the Jiangsu Nutrition Study of Chinese adults - comments by Samuels. Br J Nutr 2010;104:1729.
35. Ebert AG. Evidence that MSG does not induce obesity. Obesity (Silver Spring) 2009;17:629-30.
36. Kondoh T, Torii K. MSG intake suppresses weight gain, fat deposition, and plasma leptin levels in male Sprague-Dawley rats. Physiol Behav 2008;95:135-44.
37. Samuels A. The toxicity/safety of processed free glutamic acid (MSG): a study in suppression of information. Account Res 1999;6:259-310.
38. Samuels A. Monosodium L-glutamate: a double-blind study and review. Food Chem Toxicol 1995;33:69-78.
39. Olney JW, Ho OL, Rhee V. Brain-damaging potential of protein hydrolysates. N Engl J Med 1973;289:391-5.
40. Jequier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci 2002;967:379-88. (Pubitemid 34721923)
41. Frederich RC, Lollmann B, Hamann A, et al. Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. J Clin Invest 1995;96:1658-63.
42. Olney JW, Sharpe LG. Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 1969;166:386-8.
43. Arees EA, Mayer J. Monosodium glutamate-induced brain lesions: electron microscopic examination. Science 1970;170:549-50.
44. Pizzi WJ, Barnhart JE, Fanslow DJ. Monosodium glutamate admlinistration to the newborn reduces reproductive ability in female and male mice. Science 1977;196:452-4. (Pubitemid 8073850)
45. Simson EL, Gold RM, Standish LJ, Pellett PL. Axon-sparing brain lesioning technique: the use of monosodium-L-glutamate and other amino acids. Science 1977;198:515-7. (Pubitemid 8188138)
46. Olney JW, Ho OL. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 1970;227:609-11.
47. Olney JW. Brain damage and oral intake of certain amino acids. New York, NY: Plenum, 1976.
48. Olney JW. Excitotoxic food additives-relevance of animal studies to human safety. Neurobehav Toxicol Teratol 1984;6:455-62. (Pubitemid 15148306)
49. Olney JW. Food additives, excitotoxic. Boston, MA: Birkhauser, 1987.
50. Monno A, Vezzani A, Bastone A, Salmona M, Garattini S. Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate. Neurosci Lett 1995;193:45-8.
51. Olney JW, Labruyere J, de Gubareff T. Brain damage in mice from voluntary ingestion of glutamate and aspartate. Neurobehav Toxicol 1980;2:125-9. (Pubitemid 11197935)
52. Olney JW, Sharpe LG, Feigin RD. Glutamate-induced brain damage in infant primates. J Neuropathol Exp Neurol 1972;31:464-88.
53. Fernandez-Tresguerres Hernandez JA. [Effect of monosodium glutamate given orally on appetite control (a new theory for the obesity epidemic).] An R Acad Nac Med (Madr) 2005;122(2):341-55; discussion 55-60 (in Spanish).
54. FASEB. Analysis of adverse reactions to monosodium glutamate (MSG). Washington, DC: Life Sciences Research Office, Federation of American Societies for Experimental Biology, 1995.
55. WHO. Toxicological evaluation of certain food additives. Food Additive Series, 22. Cambridge, United Kingdom: Cambridge University Press, 1988.
56. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004;292:927-34. (Pubitemid 39097202)
57. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 2006;84:274-88. (Pubitemid 44699135)
58. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006;354:1601-13.
59. Rundlett KL, Armstrong DW. Evaluation of free D-glutamate in processed foods. Chirality 1994;6:277-82. (Pubitemid 24215092)
60. Maga JA. Flavor potentiators. Crit Rev Food Sci Nutr 1983;18:231-312.
61. Konno R, Oowada T, Ozaki A, et al. Origin of D-alanine present in urine of mutant mice lacking D-amino-acid oxidase activity. Am J Physiol 1993;265:G699-703.
62. Cram DJ, Cram JM. Host-Guest Chemistry: complexes between organic compounds simulate the substrate selectivity of enzymes. Science 1974;183:803-9.
63. Man EH, Bada JL. Dietary D-amino acids. Annu Rev Nutr 1987;7:209-25.
64. Rerucha J. The Nutrition Encyclopedia. Available from: http://www.nutripedia.com/Amino-Acids/ (cited 21 September 2009).
65. Giacometti T. Free and bound glutamate in natural products. In: Filer LJ, Garattini MR, Kare MR, Reynolds WA, Wurtman RJ, eds. Glutamic acid, advances in biochemistry and physiology. New York, NY: Raven Press, 1979.
66. American Heart Association. Available from: http://www.americanheart.org/ presenter.jhtml?identifier=3045792#def-trans-fat (cited 16 September 2009).
67. Jones-Smith J, Gordon-Larsen P, Siddiqi A, Popkin BM. Cross-national comparisons of time trends in overweight inequality by socioeconomic status among women using repeated cross-sectional surveys from 37 developing countries, 1989-2007. Am J Epidemiol 2001;173:667-75.